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previously [2]. Three isolates recovered from the
two outpatients shared PFGE type G1, clonal type
ST80-IV and agr type 3, and harboured Panton–
Valentine leukocidin genes. Only spa typing
showed a slight genetic differentiation, reﬂected
in spa types t044, t376 and t131, but there was a
clear relationship among the isolates. According
to molecular epidemiological deﬁnitions, these
three isolates were classiﬁed as CA-MRSA be-
cause they possessed SCCmec type IV and were
unrelated phylogenetically to HA-MRSA clonal
lineages described previously [3]. The remaining
isolate belonged to the Berlin MRSA clone [3],
with PFGE pattern A12, clonal type ST45-IV, agr
type 1 and spa type t015; the Panton–Valentine
leukocidin genes were not detected. No similar
strain has ever been isolated from the same
hospital, and it was therefore considered that this
isolate originated from the patient’s endogenous
ﬂora. However, the epidemic potential of the
Berlin MRSA clone has been demonstrated in
previous studies, especially in the hospital envi-
ronment [2,3].
CA-MRSA isolates have recently been reported
in hospital environments, where they can cause
nosocomial infections. However, there are also
suggestions that the increase in MRSA in the
community results largely from the introduction
of healthcare-associated strains into the environ-
ment [4]. Therefore, a deﬁnition of CA-MRSA and
HA-MRSA based on exclusively epidemiological
data might be too narrow and thus insufﬁcient.
The above ﬁndings support the overall conclusion
of Kluytmans-VandenBergh and Kluytmans [1]
that additional well-designed community-based
studies are required that use adequate risk-factor
analysis to elucidate the epidemiology of CA-
MRSA and to control the spread of MRSA.
The Croatian CA-MRSA isolates were related
genetically to the Mediterranean and Berlin
MRSA clones described previously [5,6]. This
observation, and those from other countries,
have conﬁrmed that dissemination of a single
CA-MRSA clone has not occurred, but rather that
CA-MRSA strains have arisen from diverse
genetic backgrounds in different locations [5].
Multiple genotypes of CA-MRSA are increasingly
causing community-acquired infections, and this
is particularly the case for the ST80-SCCmec IV
CA-MRSA (the ‘Mediterranean clone’), which has
disseminated among a number of European
countries [5,6].
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The interesting review on infective endocarditis
(IE) in CMI by Hill et al. [1] discussed the
changing trends in risk-factors, aetiology and
mortality during the last 20 years. We reviewed
156 cases of IE between 1995 and 2002 in a single
National Cardiology Institute in Slovakia with 180
beds (Table 1) and found a relatively high pro-
portion of cases (33.3%) with staphylococcal
aetiology, but a low incidence (14.5%) of cases
involving Streptococcus viridans. In contrast to the
observations of Hill et al. [1], no cases of Candida
IE were detected, and the prevalence of neuro-
logical complications was < 10% (compared with
20–40%). Comparing mortality rates, Hill et al. [1]
estimated 20–25% ﬁrst-year mortality, compared
with only 5.8% in our cohort, perhaps because all
156 of our cases were treated with antibiotics plus
cardiosurgical native valve (NV) replacement (17
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(12%) cases involved prosthetic valve endocardi-
tis). In our previous study in 1991–1997 [2], cases
involving surgical intervention had a signiﬁcantly
lower mortality rate than cases treated simply
with antibiotics (13.6% vs. 24.6%; p < 0.05). Thus,
early cardiosurgical intervention seems to be
important in decreasing early mortality resulting
from both native valve and prosthetic valve IE. In
this respect, the high proportion of culture-
negative cases of IE is alarming.
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Table 1. Characteristics of 156 cases of infectious endo-
carditis from a single National Cardiology Institute in
Slovakia
1995–2002
(n = 156)
1991–1997
(n = 180) [2]
Native ⁄prosthetic valve 89.1% ⁄ 10.9% 99.4% ⁄ 0.6%
Aortic ⁄mitral valve 49.4% ⁄ 23.7% 47.2% ⁄ 46.7%
Mortality rate 5.8% 22.2%a
Staphylococcus aureus 33.3% 33%
Viridans streptococci 14.5% 12.2%
Candida spp. 0 0
Culture-negative 53.3% 33.3%
aSurgical treatment, 13.6%; medical treatment, 24.6%.
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